The immunoprotein diagnostic testing market is expected to grow by $ 11.48 bnfrom 2021 to 2025, progressing at a CAGR of 8.64%, according to Technavio’s latest market report.
The report offers an up-to-date analysis and to know exact growth variance and the Y-O-Y growth rate- Request a free sample report.
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Abbott Laboratories, Bio Rad Laboratories Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann-La Roche Ltd., Merck KGaA, Siemens AG, Sofina SA, The Carlyle Group Inc., and Thermo Fisher Scientific Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The increasing prevalence of infectious diseases has been instrumental in driving the growth of the market. However, the high cost of products might hamper the market growth.
Immunoprotein Diagnostic Testing Market 2021-2025: Segmentation
- End-user
- Hospitals And Clinics
- Diagnostic Laboratories
- Geography
- North America
- Europe
- Asia
- ROW
- Application
- Oncology And Endocrinology Testing
- Infectious Disease Testing
- Autoimmune Testing
- Allergy Testing
Immunoprotein Diagnostic Testing Market 2021-2025: Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our immunoprotein diagnostic testing market report covers the following areas:
- Immunoprotein Diagnostic Testing Market size
- Immunoprotein Diagnostic Testing Market trends
- Immunoprotein Diagnostic Testing Market industry analysis
This study identifies the increasing use of immunochromatography-based cassette kits or test strips as one of the prime reasons driving the immunoprotein diagnostic testing market growth during the next few years.
Immunoprotein Diagnostic Testing Market 2021-2025: Vendor Analysis
We provide a detailed analysis of around 25 vendors operating in the Immunoprotein Diagnostic Testing Market. Backed with competitive intelligence and benchmarking, our research reports on the Immunoprotein Diagnostic Testing Market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
Subscribe to our “Lite Plan” billed annually at USD 3000 that enables you to download 3 reports/year and view 3 reports/month.
Immunoprotein Diagnostic Testing Market 2021-2025: Key Highlights
- CAGR of the market during the forecast period 2021-2025
- Detailed information on factors that will assist immunoprotein diagnostic testing market growth during the next five years
- Estimation of the immunoprotein diagnostic testing market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the immunoprotein diagnostic testing market
- Analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of immunoprotein diagnostic testing market vendors
Related Reports:
Rapid Influenza Diagnostic Tests Market –The rapid influenza diagnostic tests market size has the potential to grow by USD 0.89 billion during 2020-2024, and the market’s growth momentum will decelerate during the forecast period. Download a free sample report now!
Cervical Cancer Diagnostic Testing Market –The cervical cancer diagnostic testing market size has the potential to grow by USD 2.13 billion during 2020-2024, and the market’s growth momentum will accelerate during the forecast period. Download a free sample report now!
| Immunoprotein Diagnostic Testing Market Scope | |
| Report Coverage | Details |
| Page number | 120 |
| Base year | 2020 |
| Forecast period | 2021-2025 |
| Growth momentum & CAGR | Accelerate at a CAGR of 8.64% |
| Market growth 2021-2025 | $ 11.48 billion |
| Market structure | Fragmented |
| YoY growth (%) | 9.34 |
| Regional analysis | North America, Europe, Asia, and ROW |
| Performing market contribution | North America at 37% |
| Key consumer countries | US, Germany, UK, Canada, China, and Japan |
| Competitive landscape | Leading companies, competitive strategies, consumer engagement scope |
| Companies profiled | Abbott Laboratories, Bio Rad Laboratories Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann-La Roche Ltd., Merck KGaA, Siemens AG, Sofina SA, The Carlyle Group Inc., and Thermo Fisher Scientific Inc. |
| Market Dynamics | Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period |
| Customization purview | If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio